Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018–2021
Emerging Infectious Diseases · 2024-01 · 30 (1)
DOI: 10.3201/eid3001.230427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2024-01. Verfasst von Ntwali Placide Nsengiyumva und 16 weiteren Autor:innen. Hauptthemen laut MEDLINE: Directly Observed Therapy, Health Care Costs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Digital adherence technologies are increasingly used to support tuberculosis (TB) treatment adherence. Using microcosting, we estimated healthcare system costs (in 2022 US dollars) of 2 digital adherence technologies, 99DOTS medication sleeves and video-observed therapy (VOT), implemented in demonstration projects during 2018-2021. We also obtained cost estimates for standard directly observed therapy (DOT). Estimated per-person costs of 99DOTS for drug-sensitive TB were $98 in Bangladesh (n = 719), $119 in the Philippines (n = 396), and $174 in Tanzania (n = 976). Estimated per-person costs of VOT were $1,154 in Haiti (87 drug-sensitive), $304 in Moldova (173 drug-sensitive), $452 in Moldova (135 drug-resistant), and $661 in the Philippines (110 drug-resistant). 99DOTS costs may be similar to or less expensive than standard DOT. VOT is more expensive, although in some settings, labor cost offsets or economies of scale may yield savings. 99DOTS and VOT may yield savings to local programs if donors cover infrastructure costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Nsengiyumva, N. P., Khan, A., Gler, M. M. T. S., Tonquin, M. L., Marcelo, D., Andrews, M. C., Duverger, K., Ahmed, S., Ibrahim, T., Banu, S., Sultana, S., Morales, M. L., Villanueva, A., Efo, E., Onjare, B., Celan, C., & Schwartzman, K. (2024). Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018–2021. Emerging Infectious Diseases, 30(1). https://doi.org/10.3201/eid3001.230427
Vancouver
Nsengiyumva NP, Khan A, Gler MMTS, Tonquin ML, Marcelo D, Andrews MC, et al. Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018–2021. Emerging Infectious Diseases. 2024;30(1). doi:10.3201/eid3001.230427
BibTeX
@article{Nsengiyumva2024,
author = {Nsengiyumva, Ntwali Placide and Khan, Amera and Gler, Maricelle Ma Tarcela S and Tonquin, Mariecef L and Marcelo, Danaida and Andrews, Mark C and Duverger, Karine and Ahmed, Shahriar and Ibrahim, Tasmia and Banu, Sayera and Sultana, Sonia and Morales, Mona Lisa and Villanueva, Andre and Efo, Egwumo and Onjare, Baraka and Celan, Cristina and Schwartzman, Kevin},
title = {Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018–2021},
journal = {Emerging Infectious Diseases},
year = {2024},
volume = {30},
number = {1},
doi = {10.3201/eid3001.230427}
}
EUVIMED